- Home
- MMT vs NVCT Comparison
MMT vs NVCT Comparison
Compare MMT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMT | NVCT |
|---|---|---|
| Founded | 1987 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.2M | 220.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MMT | NVCT |
|---|---|---|
| Price | $4.65 | $9.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | ★ 78.6K | 49.0K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 8.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.31 | $5.55 |
| 52 Week High | $4.87 | $11.52 |
Technical Indicators
Market Signals| Indicator | MMT | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 38.85 | 55.32 |
| Support Level | $4.60 | $8.01 |
| Resistance Level | $4.68 | $9.20 |
| Average True Range (ATR) | 0.04 | 0.39 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 3.33 | 69.42 |
Price Performance
Historical ComparisonAbout MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.